Recurrent Rectal Cancer Completed Phase 1 Trials for Vorinostat (DB02546)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

DBCOND0028583 (Recurrent Rectal Cancer)Completed1 IdentifierTitlePurposeDrugs
NCT00138177Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsTreatment